Back

Choose your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia-Herzegovina Bosnia-Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Germany Germany Flag Hungary Hungary Flag Italy Italy Flag Kosovo Kosovo Flag Latvia Latvia Flag Lithuania Lithuania Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Montenegro Montenegro Flag Poland Poland (Lab) Flag Portugal Portugal (Lab) Flag Romania Romania (Lab) Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Spain Spain (Lab) Flag Switzerland Switzerland (Lab) Flag Sweden Sweden Flag Turkey Turkey (Lab) Flag United Kingdom United Kingdom

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
5501 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2017 Standard Therapy Poland 72
5502 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2017 Standard Therapy Poland 60
5503 Apheresis Allogeneic Chronic Myeloproliferative Neoplasm Blast Crisis Hematology 2017 Standard Therapy Poland 29
5504 Apheresis Allogeneic Common Variable Immunodeficiency, Relapsed Hemophagocytic Syndrome Hematology 2017 Standard Therapy Poland 44
5505 Apheresis Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2017 Standard Therapy Poland 61
5506 Apheresis Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2017 Standard Therapy Germany 41
5507 Apheresis Autologous Diffuse Large B-Cell Lymphoma – Relapse Hematology 2017 Standard Therapy Germany 67
5508 Apheresis Autologous Follicular B-Cell Non-Hodgkin-Lymphoma Grade I-Ii Relapse Hematology 2017 Standard Therapy Germany 59
5509 Apheresis Allogeneic Follicular Ca Hematology 2017 Standard Therapy Poland 42
5510 Apheresis Autologous Follicular Lymphoma Hematology 2017 Standard Therapy Germany 47
5511 Apheresis Allogeneic Hemophagocytosis Hematology 2017 Standard Therapy Poland 52
5512 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 25
5513 Apheresis Allogeneic Langerhans Lymphohistiocytosis Hematology 2017 Standard Therapy Poland 2
5514 Apheresis Autologous Light-Chain Myeloma Hematology 2017 Standard Therapy Germany 62
5515 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 58
5516 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 63
5517 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 61
5518 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 64
5519 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 59
5520 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 68
5521 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 50
5522 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 56
5523 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 62
5524 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 53
5525 Apheresis Allogeneic Morbus Hodgkin Hematology 2017 Standard Therapy Germany 38
5526 Apheresis Autologous Morbus Hodgkin Hematology 2017 Standard Therapy Germany 60
5527 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 61
5528 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 65
5529 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
5530 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 61
5531 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 60
5532 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 58
5533 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 61
5534 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 63
5535 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 58
5536 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
5537 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 63
5538 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 50
5539 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 52
5540 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
5541 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 57
5542 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 56
5543 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 59
5544 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
5545 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
5546 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 69
5547 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 52
5548 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 67
5549 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
5550 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
5551 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 50
5552 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 67
5553 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 53
5554 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 62
5555 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 44
5556 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 62
5557 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 56
5558 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 60
5559 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
5560 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
5561 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 60
5562 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 3
5563 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 56
5564 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
5565 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 75
5566 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 64
5567 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 64
5568 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 46
5569 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 53
5570 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 71
5571 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 50
5572 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
5573 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 67
5574 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 65
5575 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 68
5576 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 59
5577 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
5578 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 69
5579 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
5580 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 65
5581 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
5582 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
5583 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 49
5584 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 39
5585 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 67
5586 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 69
5587 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 76
5588 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 70
5589 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 53
5590 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 69
5591 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
5592 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 66
5593 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 68
5594 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
5595 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 61
5596 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 61
5597 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 22
5598 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 40
5599 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 57
5600 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63